380 results on '"Lämmle B"'
Search Results
2. Association between thyroid dysfunction and venous thromboembolism in the elderly: a prospective cohort study
3. High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence
4. Impaired DNase1‐mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies
5. Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism
6. Prospective comparison of clinical prognostic scores in elder patients with a pulmonary embolism
7. Variability of anti‐PF4/heparin antibody results obtained by the rapid testing system ID‐H/PF4‐PaGIA
8. Hereditary afibrinogenemia - long-term observation of a highly thrombogenic condition and itʼs management: OR432
9. DNA in plasma indicates disease extent and predicts mortality in patients with venous thromboembolism: OR193
10. Hereditary TTP - a young patient population with high prevalence of arterial thromboembolic events: first results from the hereditary TTP registry: OR152
11. In vitro rescue of FGA deletion by lentiviral transduction of an afibrinogenemic patientʼs hepatocytes
12. Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13)
13. Pregnancy Outcomes in Hereditary Thrombotic Thrombocytopenic Purpura – Room for (Further) Improvement.
14. ADAMTS‐13, von Willebrand factor and related parameters in severe sepsis and septic shock
15. International registry for patients with hereditary thrombotic thrombocytopenic purpura (TTP) - upshaw-Schulman syndrome: PA 4.19–1
16. Very early onset of autoimmune thrombotic thrombocytopenic purpura in five children with polynesian origin in four combined with immunodeficiency: OC 52.3
17. New strategies in diagnosis and treatment of thrombotic thrombocytopenic purpura: case report and review
18. Screening for lupus anticoagulant: improving the performance of the lupus-sensitive PTT-LA
19. Variability of anti-PF4/heparin antibody results obtained by the rapid testing system ID-H/PF4-PaGIA: reply to a rebuttal
20. Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies
21. Measurement of ADAMTS-13 activity in plasma by the FRETS-VWF73 assay: comparison with other assay methods
22. A new tool to further explore the role of ADAMTS-13 in health and disease
23. Treatment of thrombotic thrombocytopenic purpura
24. Thrombotic thrombocytopenic purpura
25. More on: thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia
26. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency
27. Usefulness of the D-dimer/fibrinogen ratio to predict deep venous thrombosis
28. Acquired deficiency of von Willebrand factor-cleaving protease in a patient suffering from acute systemic lupus erythematosus
29. Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease
30. Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods
31. Deficiency of ADAMTS-13 in thrombotic and thrombocytopenic purpura
32. Accuracy of d-dimer/fibrinogen ratio to predict pulmonary embolism: a prospective diagnostic study
33. Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukaemia
34. Subcutaneous low-molecular-weight heparin for treatment of Trousseau’s syndrome
35. Venous thrombosis after Caesarean section in a young woman with homozygous APC resistance and type I protein S deficiency
36. IFNα treatment in systemic mastocytosis
37. Komplexe Gerinnungsstörungen
38. T-18-04: The Von Willebrand factor multimer ratio and inflammatory markers in autoimmune thrombotic thrombocytopenic purpura.
39. T-17-01: Conclusion from 50 years of reports on prekallikrein or high-molecular-weight kininogen deficiency.
40. T-03-04: Neonatal exchange transfusion: hereditary thrombotic thrombocytopenic purpura (hTTP) should be in the differential diagnosis.
41. Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy
42. Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature.
43. Eleven Relapses in a Cohort of 78 Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Data from the German TTP-Registry.
44. More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?
45. Chronic interstitial nephritis in Whipple's disease
46. P1528: GENETIC AND PHENOTYPIC CHARACTERIZATION OF HEREDITARY SPHEROCYTOSIS AND RELATED DISORDERS – DESCRIPTION OF 9 NEW GENETIC VARIANTS.
47. Potential role of d‐dimer to rule in pulmonary embolism: reply to a rebuttal
48. Hereditary thrombotic thrombo-cytopenic purpura and the hereditary TTP registry.
49. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011.
50. Tryptase from human mast cells does not activate purified human Hageman Factor.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.